Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318538 | 1.00 | TSHR (0.35) | TSHRMAPK1MEN1KMT2ALPAR3 | |
| SCHEMBL876089 | 0.96 | MEN1 (0.41) | TSHRMAPK1MEN1KMT2ALPAR3 | |
| SCHEMBL874849 | 0.96 | MEN1 (0.41) | TSHRMAPK1MEN1KMT2ALPAR3 | |
| SCHEMBL876101 | 0.96 | MEN1 (0.41) | TSHRMAPK1MEN1KMT2ALPAR3 | |
| SCHEMBL875224 | 0.96 | MEN1 (0.41) | TSHRMAPK1MEN1KMT2ALPAR3 | |
| SCHEMBL875145 | 0.96 | MEN1 (0.41) | TSHRMAPK1MEN1KMT2ALPAR3 | |
| Ethylene Glycol SCHEMBL10536746 | 0.88 | ALDH1A1 (0.32) | TSHRLPAR3LPAR2ALDH1A1 | |
| SCHEMBL10536751 | 0.87 | TSHR (0.35) | TSHRMEN1KMT2ALPAR3LPAR2 | |
| SCHEMBL10955085 | 0.85 | TSHR (0.33) | TSHRLPAR3LPAR2ALDH1A1 | |
| SCHEMBL534005 | 0.83 | TSHR (0.38) | TSHRLPAR3LPAR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321254-B1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2014-07-30 | — | — | EP | disclosed |
| US-8420709-B2 | Coating composition, (meth)acrylic polymer and monomer mixture for producing the (meth)acrylic polymer | EVONIK RÖHM GMBH (DE) | 2013-04-16 | — | — | US | disclosed |
| US-8415422-B2 | (Meth)acrylate monomer, polymer and coating agent | EVONIK RÖHM GMBH (DE) | 2013-04-09 | — | — | US | disclosed |
| WO-2012038197-A1 | COATING AGENT HAVING (METH)ACRYLIC POLYMERS AND COALESCENCE ADDITIVES | EVONIK RÖHM GMBH (DE) | 2012-03-29 | — | — | WO | disclosed |
| EP-2414412-A1 | (METH)ACRYLATE POLYMER, COATING AGENT, METHOD FOR PRODUCING A COATING, AND COATED OBJECT | Evonik Röhm GmbH (DE) | 2012-02-08 | — | — | EP | disclosed |
| EP-2414462-A1 | COATING COMPOSITION, (METH)ACRYL-POLYMER AND MONOMER MIXTURE FOR PRODUCING SAID (METH)ACRYL-POLYMER | Evonik Röhm GmbH (DE) | 2012-02-08 | — | — | EP | disclosed |
| EP-2414413-A1 | POLYFUNCTIONAL (METH)ACRYLIC POLYMER, COATING COMPOSITION, PROCESS FOR PRODUCING A COATING AND COATED ARTICLE | Evonik Röhm GmbH (DE) | 2012-02-08 | — | — | EP | disclosed |
| US-20120016071-A1 | POLYFUNCTIONAL (METH)ACRYLIC POLYMER, COATING COMPOSITION, PROCESS FOR PRODUCING A COATING AND COATED ARTICLE | EVONIK ROEHM GMBH (DE) | 2012-01-19 | — | — | US | disclosed |
| WO-2012004160-A1 | COMPOSITION FOR PRODUCING POLYMERS, (METH)ACRYLIC POLYMER, COATING AGENT, AND COATING | EVONIK RÖHM GMBH (DE) | 2012-01-12 | — | — | WO | disclosed |
| US-20110318595-A1 | COATING COMPOSITION, (METH)ACRYLIC POLYMER AND MONOMER MIXTURE FOR PRODUCING THE (METH)ACRYLIC POLYMER | EVONIK ROEHM GMBH (DE) | 2011-12-29 | — | — | US | disclosed |
| EP-1201657-B1 | Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst | CENTRE NAT RECH SCIENT (FR) | 2004-05-06 | — | — | EP | disclosed |
| US-20040026666-A1 | Imidazolium salts and their use of these ionic liquids as a solvent | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2004-02-12 | — | — | US | disclosed |
| EP-1328518-A1 | IMIDAZOLIUM SALTS AND THE USE OF THESE IONIC LIQUIDS AS A SOLVENT | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2003-07-23 | — | — | EP | disclosed |
| US-6525228-B2 | Reacting a conjugated diene with a compound containing active hydrogen in the presence of a cataylst system comprising a transition metal compound, a phosphorus containing compound and atleast one salt | CELANESE CHEMICALS EUROPE GMBH (DE) | 2003-02-25 | — | — | US | disclosed |
| US-20020091281-A1 | Process of telomerizing conjugated dienes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2002-07-11 | — | — | US | disclosed |
| EP-1201634-A1 | Process of telomerizing conjugated dienes | Celanese Chemicals Europe GmbH (DE) | 2002-05-02 | — | — | EP | disclosed |
| EP-1201657-A1 | Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2002-05-02 | — | — | EP | disclosed |
| WO-2002034722-A1 | IMIDAZOLIUM SALTS AND THEIR USE OF THESE IONIC LIQUIDS AS A SOLVENT | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2002-05-02 | — | — | WO | disclosed |
| US-4843180-A | Preparation of ethers | THE DOW CHEMICAL COMPANY (US) | 1989-06-27 | — | — | US | disclosed |
| US-4334117-A | DIMERIZATION OF BUTADIENE/1,3-/ AND ISOPRENE | KURARAY CO., LTD. (JP) | 1982-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091281-A1 | Process of telomerizing conjugated dienes | TELO2, TERT, PCNA | TSHR 2595/4885MAPK1 1446/4885MEN1 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.